Introduction
Calponin (Cnn) was originally described as an actin filament-associated protein capable of binding to F-actin, calmodulin, and tropomyosin [1] [2] [3] [4] [5] . It exhibits in vitro inhibitory properties of the actomyosin MgATPase and therefore has been postulated to play a role in smooth muscle contraction [1, [6] [7] [8] . In addition, Cnn has been shown to stabilize the actin cytoskeleton, to induce actin polymerization, to stabilize cross-linked actin networks, and to interact with a variety of additional cytoskeletal and cytoskeleton-associated proteins, such as myosin, tubulin, a-actinin, and others [9] [10] [11] . Based on the N-terminal Cnn homology domain and a second middle region containing two actin-binding sites, three Cnn family members have been identified. These isoforms termed calponin 1/2/3 (Cnn1/2/3; previously described as basic, neutral, and acidic Cnn, respectively) exhibit an additional unique C-terminal region. Interestingly, all three Cnn isoforms show cell type and tissue-specific expression, with Cnn1 being restricted to smooth muscle cells and exhibiting its function in regulating fine tuning of smooth muscle contractility [12] [13] [14] . Cnn2 is expressed in both smooth muscle and nonmuscle cells where it participates in various actin cytoskeleton-based functions, regulating cell proliferation, migration, adhesion, phagocytosis, angiogenesis, immune response, and cancer metastasis in the latter [15] [16] [17] [18] . Similarly, Cnn3 is expressed in smooth muscle, but is also found in nonmuscle tissue, especially in the postnatal nervous system, where it localizes to neurons, astrocytes, and glial cells. Cnn3 function implicates the regulation of the actin cytoskeleton reorganization and dynamics [19] [20] [21] [22] . During embryonic development, Cnn3 is expressed in myoblasts and is known to play a crucial role in trophoblast cell fusion via regulating the rearrangement of the actin cytoskeleton [23] [24] [25] .
To date, little is known about the function of Cnn3 in nonmuscle tissue, especially on its potential roles during embryonic development and morphogenesis. Cnn3 is strongly expressed in the brain, with a proposed function during neuronal remodeling and dendritic spine plasticity due to its function as an actin filament regulator [20, 22, 26, 27] . In zebrafish, Cnn3 has been described as a downstream target gene of Otx2 preventing convergence extension movements [28] . We have recently investigated the role of Cnn3 during B-cell development by applying a loss-of-function mouse model and found that loss of Cnn3 severely affects embryonic brain development in vivo [29] . Here, we have analyzed these Cnn3-deficient animals in more detail during embryonic development and observed massive malformations of the anterior neural tube such as neural tube closure defects already at early stages of development. At birth, Cnn3 À/À littermates exhibited massive enlargement of brain structures and exoencephaly accompanied by a loss of dorsal skull bones. The failure of neural tube closure was restricted to anterior structures and excluded from the spinal cord. We observed Cnn3 as being localized adjacent to beta-Catenin/N-Cadherin-mediated adhesion junctions in the developing neuroepithelium (NE) and found activation of the canonical Wnt-signaling pathway after ablation of Cnn3. Finally, in an attempt to better understand the observed increase of brain tissue in Cnn3 null animals, we examined the impact of Cnn3 in embryonic neuronal stem cells (NSC) and provide evidence that the ablation of Cnn3 leads to an increase in proliferation of NSCs without perturbing their differentiation potential. In summary, this study provides for the first time insights into the important role of Cnn3 during early embryonic development and furthermore provides evidence for a crucial role of Cnn3 in NSC function.
Results

Cnn3
À/À embryos exhibit exoencephaly
We have recently generated mutant mice deficient in Cnn3 (Cnn3 À/À ) derived from crossings of floxed (fl)
+/fl mutants with cre-deleter animals [29] . To gain a deeper understanding into the function of Cnn3, we generated straight Cnn3 null mutants by crossing Cnn3 +/À animals and observed a 100% death rate of Cnn3 À/À littermates within the first day after birth.
Therefore, we examined Cnn3 À/À embryos at various time points of development in detail. Our analysis revealed that Cnn3 À/À embryos exhibit massive malformations of the developing brain already at embryonic day 10.5 ( Fig. 1A) . At this time point, the neural tube of wild-type embryos has already closed. In contrast, Cnn3 À/À embryos exhibited an open neural tube from Interestingly, already at embryonic day 10.5, the size of the embryonic brain, especially of the mesencephalic tissue, appeared enlarged. Caudal of the rhombencephalon starting from the level of the otic vesicle, the neural tube of the spine had closed (Fig. 1A , arrow dorsal view). At the beginning of our studies, we realized that the degree of neural tube closure defects at the level of the spine varied within the group of mutant littermates. By backcrossing of our breeder animals onto a SV129 genetic background, these variations became eliminated. At embryonic days 12.5 and E14.5 of development, the enlargement of mutant brains became more distinct (Fig. 1B,C) . At E14.5, an exoencephaly was clearly visible, and the brains of Cnn3 À/À embryos were exposed toward the outside. Cartilage/bone structures of the anterior dorsal head structures appeared to be missing, and the enlarged brain tissue was covering the head of the mutant embryos (Fig 1C, arrowheads) . A strongly pronounced exoencephaly phenotype was observed at embryonic day E18.5 ( Fig. 1D, arrowhead) . Of note, all Cnn3 À/À embryos analyzed at day E18.5 exhibited visible coagulated blood in the malformed brain (Fig. 1D , open arrowhead). Homozygous mutant littermates were not viable after birth. If Cnn3 À/À littermates were born alive, all animals died shortly afterward. No milk was found in the stomach of newborns. Sectioning of mutant embryos and subsequent histochemical analysis revealed the degree of brain malformation in more detail (Fig. 1E-G) . On transverse sections of Cnn3 À/À embryos at day E12.5, one can see that the neural tube of the future brain did not fuse and close and that the apical side of the NE is exposed toward the outside (Fig. 1E, open arrowhead) . The head mesenchyme normally covering the neuroepithel was laterally enclosed by the NE (Fig. 1E , arrowhead) with its dorsal part coming close to the lateral surface of the head (Fig. 1E, arrow) . In contrast, the neural tube of the caudal spine did not show a failure in closing (Fig. 1E , open arrows). Coronal and sagittal sections of E18.5 Cnn3
animals exhibited a similar phenotype with apical structures especially of the midbrain being exposed to the outside (Fig. 1F,G formed Alcain staining at embryonic days E14.5 and 17.5. We observed that already at day E14.5, embryos were missing the structures forming the future frontal, parietal, and interparietal skull bones (Fig. 1I) . A similar scenario was observed at day E17.5 with a loss of frontal, parietal, and interparietal bone/cartilage structures, which are enclosing the head during normal development ( Fig. 1J ).
Cnn3 is localized to the ventricular apical lining
To gain insight into the localization of Cnn3 in the developing mouse brain, we performed a detailed immunohistochemical analysis (Fig. 2) . Interestingly, when analyzing E14.5 brains of wild-type animals, we observed strong Cnn3 immunoreactivity at the apical lining of the NE of the telencephalon as well as in third and fourth ventricles ( Fig. 2A ,B and data not shown), indicating a close localization to the endfeet of apical progenitor cells or apical adhesion structures. Therefore, we performed immunofluorescence studies using E9.5 wild-type embryos ( Fig. 2C -G) and again found Cnn3 localized to the apical membrane of the neural tube. Co-labeling with anti-beta-Catenin antibodies indeed revealed a localization of anti-Cnn3 immunoreactivity directly at or adjacent to the adhesion junctions of the apical endfeet of neuroepithelial cells ( Fig. 2C-D) . Beta-Catenin as part of the adhesion junction complex showed strong colocalization with Cnn3 at the apical endfeet ( Fig. 2E , arrowheads). However, high-power magnification of the apical endfeet also demonstrated that immunolabeling of beta-Catenin and Cnn3 were not entirely overlapping (Fig. 2E‴ ). Beside areas with a complete overlap, many areas showed beta-Catenin labeling adjacent to the Cnn3 labeling ( Fig. 2E‴ , open arrowhead). To substantiate this finding, we performed z-axis sectioning and threedimensional reconstruction analysis (Fig. 2F ). Although we found to some extend a complete overlap of Cnn3 and beta-Catenin immunofluorescence (data not shown), the majority of analyzed areas showed labeling of Cnn3 and beta-Catenin directly adjacent to each other ( Fig. 2F″ including xy and xz projections). We obtained similar results when performing coimmunolabeling with anti-Cnn3 and anti-N-cadherin. However, complete overlapping immunoreactivity was observed to a lower degree as with anti-beta-Catenin. Nevertheless, as seen for beta-Catenin also, N-Cadherin immunoreactivity was found directly adjacent to Cnn3 immunolabeling (Fig. 2G) . From these data, we conclude that Cnn3 is localized to or adjacent to the apical adhesion complex of neuroepithelial cells and might play an important role in regulating the function of neuroepithelial cells and apical progenitors in the developing mouse brain.
Cnn3
À/À embryos exhibit higher levels of betaCatenin-mediated Wnt signaling within the neuroepithelium In order to verify the neural tube closure defect and to understand the processes underlying this phenotype, we analyzed whether the NE of Cnn3 À/À embryos had lost its polarization. To do so, we stained wild-type and deficient embryos at day E9.5 with anti-PKC-zeta antibodies and found that the NE possesses an apicalbasal polarization even in the absence of Cnn3 (Fig. 3A,B) . Due to the closure failure of the anterior neural tube, the apical surface of the NE became exposed to the outside, whereas in wild-type mice that apical surface was exposed to the lumen. As the Bmp signaling pathway has been described to be a major regulator of the process that finally leads to the closure of the neural tube, we wondered whether Cnn3 À/À embryos exhibit altered Bmp signaling and used anti-p-Smad1/5/8 immunohistochemistry to address this question. At embryonic day E10.0, we observed a salt and pepper-like staining of antip-Smad1/5/8 in wild-type animals, with cells being lined up at the apical side of the NE (Fig. 3C , arrowheads). In contrast, Cnn3 À/À embryos showed a strong increase of p-Smad1/5/8 positive cells in the nonclosed NE. These cells were found localized more at the apical side of the NE, which is exposed to the outside due to the failure of neural tube close and which represents dorsal structures in wild-type animals (Fig. 3D, open  arrowheads) . Next, we performed immunohistochemical staining to detect beta-Catenin in Cnn3
À/À mutants. To our surprise, we observed anti-beta-Catenin labeling not restricted to the apical lining of the NE (Fig. 3E,F, arrows) . While anti-beta-Catenin labeled the apical lining and no staining was seen in the cytosol or nuclei of the NE in wild-type embryos (Fig. 3E , arrowhead and open arrowhead), loss of Cnn3 resulted in a strong nuclear staining in the lateral NE representing the dorsal domains (Fig. 3F  arrows) . This labeling was restricted to the tip of the NE. In ventral domains, no anti-beta-Catenin labeling was seen within the NE. We confirmed this finding by immunofluorescence labeling (Fig. 3G, arrow) . At the tip of the NE, representing its dorsal domain, embryos displayed strong fluorescence immunolabeling. Aside from the tip, typical circular endfeet staining of betaCatenin was observed (Fig. 3G) . Next, we analyzed mitotic activity by conducting anti-phospho-histone 3 (H3) labeling. Histone H3 phosphorylation at Ser(10) occurs during mitosis in eukaryotes and is tightly correlated with chromosome condensation. Therefore, it can be used to identify cells undergoing mitosis [30] [31] [32] . Interestingly, we found strong anti-phospho-H3 labeling again at the tip of the NE representing the dorsal domain (Fig. 3H, arrowhead) . High levels of nuclear beta-Catenin are a hallmark of active canonical Wnt signaling and increased ectopic Wnt activity is often going along with an onset or increased proliferation. We, therefore, hypothesized that the loss of Cnn3 in the early NE might cause an increase in canonical, beta-Catenin-mediated Wnt activity. To substantiate this hypothesis, we crossed Cnn3 +/À onto a BAT-gal Wnt-reporter mouse line and generated Cnn3-deficient embryos carrying the BATgal reporter allele [Cnn3 À/À :Tg(BAT-lacZ)]. In animals carrying the BAT-gal allele, Wnt activity can be visualized and measured due to the activation of a transgenic lacZ allele, which is under the control of a triple Wnt-promoter element. We collected all littermates of one mother and stained them in parallel with X-gal solution. In contrast to wild-type or heterozygous Cnn3 +/À animals, null mutants showed an extremely strong blue X-gal staining of the brain already after 1 min (Fig. 3I) , especially in the most lateral areas (outer edge) of mesencephalon that has been folded toward the outside (Fig. 3I, open arrowheads) . In controls, X-gal staining was even after 6-8 min of incubation restricted to the dorsal midline especially of the mesencephalon. Together, these data suggest that Cnn3 À/À embryos exhibit increased levels of Wnt activity at the outer areas of the nonclosed neural tube at E9.5.
Loss of Cnn3 results in an increased number of neuronal stem cells
In respect to the increase of brain tissue size in Cnn3
À/À embryos, we isolated embryonic NSCs and used the neurosphere assay to analyze their proliferation and differentiation potential. In this assay, the number of formed spheres is a direct readout of the number of NSC that had been present. We first measured the sphere forming potential by generating tertiary (thirdgeneration) neurospheres and counting their number. We analyzed tertiary neurospheres to avoid formation of spheres formed by non-NSC in primary cultures. Intriguingly, we found 40% more neurospheres generated in cultures of Cnn3 À/À embryos as compared with controls ( Fig. 4A) . Similar results were obtained with spheres formed after the fourth plating (data not shown). This indicates that Cnn3-deficient NSCs are proliferating faster or are undergoing more symmetric cell divisions, thereby leading to a higher number of stem cells in each sphere formed. Moreover, while analyzing our neurosphere cultures, we realized that spheres formed from Cnn3 À/À embryos were of bigger size than spheres from control animals. To quantify this, we measured the diameter of tertiary control and Cnn3 À/À spheres and found a statistically significant increase in the latter (Fig. 4B) . Besides self-renewal capacity and proliferation, we also examined the differentiation potential of Cnn3 NSCs. In particular, we generated tertiary neurospheres, plated these at clonal density, cultured them for 6 days and analyzed them subsequently by immunohistochemistry. We observed that Cnn3-deficient neurospheres were able to form astroglia, precursors, oligodendroglia and neurons in analogy to wildtype neurospheres (Fig. 4C-F and data not shown) . These data indicate that the loss of Cnn3 in embryonic NSCs increases the self-renewing potential but does not affect their differentiation potential in vitro.
To examine whether Cnn3 À/À embryos exhibit increased proliferation also in vivo, we performed bromodeoxyuridine (BrdU) pulse labeling experiments at embryonic day E18.5. We administered BrdU 18.5 days after fertilization and analyzed BrdU incorporation 2 h later by immunohistochemistry (Fig. 4G-I ). Whereas hardly any BrdU incorporation was detected in wild-type littermates, Cnn3 À/À null mutants showed strong BrdU-positive labeling in the VZ/SVZ of the brain (Fig. 4H,I , open arrowheads). Importantly, we found BrdU incorporation also in cells at the most outer area of the brain tissue that had been grown out and was covering the head of the embryo (Fig. 4H, arrowhead) . This tissue is most likely of mesencephalic origin as our embryonic analysis suggests. These data indicate that at day E18.5, proliferation in the exoencephalic brain of Cnn3
embryos is still ongoing within the VZ/SVZ and within misplaced tissues exposed to the outside. This increased and ectopic proliferation might account for the massive increase in brain size observed in Cnn3-deficient mutants.
Discussion
We aimed with this study to gain further information about a possible role of Cnn3 during embryonic development. Cnn3 À/À littermates lacking Cnn3 exhibit massive malformation of the developing brain. The first obvious visible phenotype, a failure in neural tube closure, is clearly visible already at E9.5. In mice, the neural tube closure is initiated at the hindbrain/cervical boundary, at the midbrain/forebrain boundary, and at the most anterior part of the telencephalon from where closure spreads into the remaining areas of the neural tube [33] [34] [35] [36] . Based on our observations, we suggest that Cnn3 À/À embryos might have a failure of closure at the second closure initiation point at the midbrain/forebrain boundary. This idea is supported by the following observations: First, the observed neural tube closure defect in Cnn3 À/À animals appears to be restricted to the mesencephalic area. Second, closure at the hindbrain/cervical boundary appears at around E8.5 and Cnn3 À/À mutants exhibited closure defects in this region only very rarely. Similarly, we did not observe a failure of closure at the anterior forebrain. In wild-type animals, closure initiation at the midbrain/forebrain boundary occurs around E9.0, which also is in agreement with our observation since closure defects in Cnn3 À/À animals became visible around E9.5. It appears that cranial neural tube closure has a high dependency on cytoskeleton-mediated events. Of note, of the many genes that have been identified to cause neural tube closure defects, the group of cytoskeleton proteins and its regulators are known to cause preferentially cranial compared with spinal closure defects. Taken in account the described role of Cnn3 as a regulator of the actin cytoskeleton, the observed phenotype in Cnn3 mutants is in line with this observation. Interestingly, Cnn3 À/À mutants are also missing the structures forming the future frontal, parietal, and interparietal skull bones, which are neural crest and paraxial mesoderm derivatives. Similar observations have been reported in many other mouse mutants that exhibit a tube closure defect in the anterior neural tube [33, 37] . This phenotype is most likely a secondary effect caused by the failure to close the neural tube, rather than a specific consequence of Cnn3 deletion. The defect in neural tube closure is very likely also causing the subsequent failure of the left and right sheets of the non-neural surface ectoderm to fuse at the dorsal midline and to detach from the neural tube. However, although the failure of tube closure was evident already at early time points, Cnn3 À/À brains appear to have an increased mass of brain tissue. Interestingly, we found that BrdU pulse labeling at E18.5 revealed a massive increase of BrdU incorporation in cells located in the VZ and SVZ of the developing brain. Therefore, we raised the question whether the early loss of Cnn3 in our mutants might have an influence on the proliferation of neuronal precursors/ NSCs. We analyzed NSCs function of Cnn3 mutants in vitro to avoid secondary signaling effects caused by the failure of tube closure. Our analysis using Cnn3
tertiary neurospheres clearly revealed an almost twofold increase in sphere forming potential, indicating that Cnn3-deficient NSCs are either proliferating faster or undergo more symmetric cell divisions leading to a higher number of stem cells in each sphere formed. Interestingly, we also observed that the diameters of Cnn3 À/À neurospheres were significantly larger compared with control spheres and that these spheres produced significantly more multipotent stem cells leading to the generating of more new neurospheres upon subcloning. This indicates that the loss of Cnn3 increases the proliferation rate of stem/progenitor cells in culture. In agreement with our findings, Cnn1 and Cnn2 displayed a decrease in cell proliferation in various cell types after overexpression [15, 38] . Of note, although mutant embryos exhibit a massive increase in brains tissue, the overall development of the brain appeared fairly robust. In Cnn3 À/À mutants, the polarization of epithelial cells does not change, and importantly, stratification and neuronal differentiation is present. Together, these data indicate that Cnn3 might play an important function in the regulation of NSC proliferation.
Remarkably, Cnn3 À/À NSC do not lose their differentiation potential in vitro. We observed that Cnn3
À/À neuronal stems cells were able to differentiate into astrocytes, oligodendrocytes, precursors, and neurons. In contrast, Cnn3 has been found up-regulated when applying neuronal differentiation protocols to human umbilical cord mesenchymal stem cells and overexpression in postmitotic cells led to stabilization of F-actin filaments and an up-regulation of ionotropic glutamate receptor complexes as well as an increase in spine density and length [22, 39] . In wild-type situations, Cnn3 has also been shown to accumulate at the postsynaptic density [19, 26, 27] . These postmitotic processes in neurons such as Glu1 receptor complex formation, spine elongation, spine formation, and postsynaptic structural dynamics all require a precise and dynamic reorganization and stabilization of the F-actin filament network. Taken in account our knowledge of Cnns in regulating actin networks and function, these findings strengthen the idea that also in these dynamic processes Cnn3 might play an important role. For future analysis, it would be important to address its role in filament associated and other dynamic processes by tissue-specific Cnn3 deletion in postmitotic/mature neurons. From its known function as a stabilizer of actin filaments [9] [10] [11] , it was not surprising that we identified Cnn3 as being localized to the apical lining of the NE in close vicinity to the adhesion junctions formed by beta-Catenin and N-Cadherin. It is believed that a rearrangement of the actin cytoskeleton at the apical side of the NE is one crucial step during correct neural tube folding as it appears to be a prerequisite in changing the shape of the neural folds from a flat to a more concave shape and, as mentioned before, many cytoskeleton regulators have been identified to cause cranial neural tube closure defects when disturbances in their expression or function are present [40] [41] [42] [43] [44] [45] [46] . The importance of apical adhesion in neural tube closure is also supported by a recent study in which Ephrin B1 has been shown to regulate apical adhesion via integrin b1-mediated adhesion. Here, loss of Ephrin B1 caused neural tube closure defects and exoencephaly very similar to Cnn3 mutants [47] . In view of its role as a regulator of actin filaments, it was to some extend surprising when we identified additionally key molecules of the canonical Wnt and Bmp/TGF-b pathway as being activated or up-regulated in Cnn3 À/À embryos. It is known that Bmp signaling plays a fundamental role in neural tube closure and Cnn3 has been shown to interact with Smad 1 and 5 [48] . In addition, mutants of the Bmp pathway exhibit striking similarities to the present phenotype [49] . So far, no interaction of Cnn3 with Wnt/beta-Catenin-signaling components has been demonstrated. However, there is increasing evidence that also actin cytoskeleton reorganization and regulators might be able to activate and regulate Wnt/beta-Catenin signaling [50, 51] . In addition, a direct regulation of Cnn3 function by Rho, Rock and other cytoskeleton regulators has been demonstrated [24, 52] . Of note, most of these regulators play a crucial role in neural tube closure. We are tempted to speculate that the presence of nuclear betaCatenin could be a reason of the induced proliferation of NSC, as nuclear beta-Catenin is known to induce proliferation [53] [54] [55] [56] . Interestingly and in contrast, premature neurogenesis and early exit from the cell cycle within the NE are also often leading to neural tube closure defects. Therefore, we think that the observed neural tube closure defect in the Cnn3 À/À embryos is not solely caused by a perturbed cell cycle. Since affecting the fine tuning of the actin cytoskeleton can interfere with several fundamental signaling cascades and cellular processes, it is difficult to answer the question what comes first and which process second. We speculate that ablating Cnn3 at early stages of development might interfere with crucial cytoskeletondependent processes all necessary for a precise coordination of neural tube development.
In conclusion, we identified Cnn3 as an important gene in regulating correct neural tube morphogenesis and raised evidence for a role of Cnn3 in regulating NSC proliferation. In order to avoid secondary effects raised by ablating Cnn3 in all cells as done in this study, single cell ablation studies by using, for example, in utero electroporation and conditional cell typespecific deletions by using Cnn3 fl/fl animals will help to uncover the precise cellular role of Cnn3 in neural tube development. In addition, these approaches might help to uncover whether Cnn3 exhibits direct roles in regulating crucial signaling pathways or whether these pathways are affected due to perturbances of neighboring tissues. 
Materials and methods
Ethics statement
Animals
Heterozygous Cnn3
+/À mice and animals carrying the BATGal reporter transgene were maintained on a 129SvEv background [29, 57] . The day of birth was considered postnatal day (P) 0. Embryos were obtained from timed pregnancies, with plug date defined as embryonic day E0.5. For BrdU incorporation studies, pregnant mice were injected intraperitoneally with a sterile solution of BrdU (50 mgÁkg
À1
; Roche Diagnostics, Mannheim, Germany) in PBS.
Histological analysis and immunohistochemistry
For immunohistochemical analysis of embryos, these were dissected and fixed in 4% paraformaldehyde/PBS for 20 min at room temperature (RT) or over night at 4°C (depending on developmental stage). After ethanol dehydration and paraffin embedding, 7-lm microtome sections were cut and transferred to glass slides (Super frost, Thermo Fisher Scientific, Waltham, MA, USA). After rehydration, sections were incubated in citrate buffer (3.9 
Antibodies
The following antibodies were used in this study: antibeta-Catenin ( 
Cell culture
Neurosphere assays were performed according to standard protocols [58, 59] . We generated neurospheres from E12.5 forebrain and midbrain tissue and cultured them in the presence of Fgf2 (for detailed protocols see references). Equal numbers of cells from the dissociated tissues were cultured for 6 days. Then, neurospheres were dissociated, passaged (1000 cells plated) and cultured again for 6 days before the final passaging to generate tertiary neurosphere cultures, which were used for analysis.
To measure the neurosphere forming potential, tertiary neurospheres were cultured for 5 days before counting their number in 24-well plates using a Zeiss stereomicroscope. To assess the neurosphere differentiation potential, tertiary neurospheres were induced to differentiate by plating on poly-L-lysine/laminin-coated plates and cultured in neurosphere medium at a density of 30 spheres/35 mm culture dish. After 5 days, the plated cells were fixed with 4% paraformaldehyde and immunofluorescent analysis of protein expression was performed with antibodies against GFAP, Nestin, O4, and TuJ1. To quantify the size distribution, tertiary neurospheres were collected and photographed using phase contrast light microscopy, and the diameter was measured using Axiovision software (Zeiss).
